Catalyst Pharmaceutical Partners Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
10 Best Defensive Stocks To Invest In 2023
Article By: Elliottwave Forecast
Wednesday, October 11, 2023 11:21 AM EDT
A defensive stock is a stock that demonstrates relatively stable performance regardless of the current state of the economy. Defensive stocks are less prone to the economic cycle of expansions and recessions.
In this article: JPM, KO, KR, NJR, PFE, WEN, BTI, CALM, AAPL, CPRX
Read
Top Picks For 2023: Catalyst Pharmaceuticals - Sunday, Jan. 8
Article By: MoneyShow.com
Sunday, January 8, 2023 5:01 PM EDT
For a growth-oriented choice for the new year, I'm going with under-the-radar company, Catalyst Pharmaceuticals. Let's take a look at the company's fundamentals, technicals, and institutional support to see if it's a good pick for 2023.
In this article: CPRX
Read
Top Picks For 2023: Catalyst Pharmaceuticals
Article By: MoneyShow.com
Monday, January 2, 2023 12:30 PM EDT
Catalyst Pharmaceuticals is a small-cap biopharma company focused on in-licensing, developing, and commercializing novel medicines to treat rare diseases. Let's take a closer look to see why it's a top pick for 2023.
In this article: CPRX Also: ESALY, BMRN
Read
5 Stocks Analysts Recommend Heading Into 2020
Article By: Benzinga
Wednesday, January 1, 2020 2:37 PM EDT
The S&P 500 closed out 2019 with another strong month in December. However, analysts remain optimistic on some top stocks heading into 2020. Here’s a look at several stocks analysts recommend.
In this article: GLUU, AMZN, CPRX, VSLR, VKTX
Read
Catalyst Defends Firdapse Pricing In Response Letter To Bernie Sanders
Article By: The Fly
Thursday, February 21, 2019 4:08 PM EDT
The pharmaceutical company takes exception to Sanders' complaint.
In this article: CPRX
Read

Latest Tweets for $CPRX

No tweets yet!

PARTNER HEADLINES